Carrie Brodmerkel

7.0k citations
58 papers · 3.4k indexed · 1 hit paper · h-index 28

Carrie Brodmerkel

55 papers receiving 3.3k citations

Hit Papers

Efficacy and safety of ustekinumab in patients with activ...6062013202620172021200400600

Peers

Carrie Brodmerkel
Comparison fields: 5 of 114
  • Dermatology 891
  • Immunology 1.9k
  • Rheumatology 867
  • Hematology 499
  • Physiology 623
Replace Paul Klekotka with:
Paul Klekotka United States
Robert Matheson United States
C. Papavassilis Germany
Jörg C. Prinz Germany
Newman Yeilding United States
B. Randazzo United States
G Stingl Austria
Bernard S. Goffe United States
Howard Sofen United States
Brian V. Jegasothy United States
Carrie Brodmerkel relative to Paul Klekotka United States Paul Klekotka's profile →
Citations per field
00.5×2.8×
Paul Klekotka · 1×
Citations per year

Countries citing papers authored by Carrie Brodmerkel

Since Specialization
Citations

This map shows the geographic impact of Carrie Brodmerkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie Brodmerkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie Brodmerkel more than expected).

Fields of papers citing papers by Carrie Brodmerkel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie Brodmerkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie Brodmerkel. The network helps show where Carrie Brodmerkel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carrie Brodmerkel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carrie Brodmerkel Line = papers co-authored together Carrie Brodmerkel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2018125
2 201854
3 201821
4 201642
5 201645
6 201527
7 201525
8 20152
9 201510
10 20141
11 2014220
12
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialbreakdown →
2013606
13 201338
14 2012149
15 201222
16 2011260
17 2011104
18 201160
19 20101
20 20033

About Carrie Brodmerkel

Carrie Brodmerkel is a scholar working on Immunology, Dermatology and Genetics, having authored 58 papers that have together received 3.4k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (19 papers), Inflammatory Bowel Disease (16 papers), Dermatology and Skin Diseases (10 papers), Microscopic Colitis (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Cytokine Signaling Pathways and Interactions (7 papers). The work is most often cited by research in Dermatology (891 citations), Immunology (1.9k citations) and Rheumatology (867 citations). Carrie Brodmerkel has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Katherine Li, James G. Krueger, Mayte Suárez‐Fariñas, Yuhua Wang, Alice B. Gottlieb, Iain B. McInnes, Alan M. Mendelsohn, L. Puig, Arthur Kavanaugh and Christopher T. Ritchlin. Their work appears in journals such as The Lancet, Nature Biotechnology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026